Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies

por Demminger, Daniel E, Walz, Lisa, Dietert, Kristina, Hoffmann, Helen, Planz, Oliver, Gruber, Achim D, von Messling, Veronika, Wolff, Thorsten
Publicado 2020

A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9

por Hörner, Cindy, Fiedler, Anna H., Bodmer, Bianca S., Walz, Lisa, Scheuplein, Vivian A., Hutzler, Stefan, Matrosovich, Mikhail N., von Messling, Veronika, Mühlebach, Michael D.
Publicado 2023

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial

por Aldrich, Cassandra, Leroux–Roels, Isabel, Huang, Katell Bidet, Bica, Mihai Alexandru, Loeliger, Edde, Schoenborn-Kellenberger, Oliver, Walz, Lisa, Leroux-Roels, Geert, von Sonnenburg, Frank, Oostvogels, Lidia
Publicado 2021

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial

por Kremsner, Peter G., Mann, Philipp, Kroidl, Arne, Leroux-Roels, Isabel, Schindler, Christoph, Gabor, Julian J., Schunk, Mirjam, Leroux-Roels, Geert, Bosch, Jacobus J., Fendel, Rolf, Kreidenweiss, Andrea, Velavan, Thirumalaisamy P., Fotin-Mleczek, Mariola, Mueller, Stefan O., Quintini, Gianluca, Schönborn‑Kellenberger, Oliver, Vahrenhorst, Dominik, Verstraeten, Thomas, Alves de Mesquita, Margarida, Walz, Lisa, Wolz, Olaf‑Oliver, Oostvogels, Lidia
Publicado 2021